Royalty Pharma Sub-Manager, LLC

Position in BHVN — Biohaven Ltd.

CIK 2081668 New York, NY

Position in BHVN

as of Jun 30, 2026 · filed Aug 21, 2026 Compact

Position Value

$43,695,224

+$18,852,375 QoQ

Shares Held

2,936,507

0.0% QoQ

Ownership

1.94%

of shares outstanding

% of Portfolio

18.06%

of 13F equity value

Holder Rank

#12

of 294 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Royalty Pharma Sub-Manager, LLC holds $241,917,579 across 4 Biotechnology names. BHVN ranks #4 (18.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	980,392	$83,519,594
2	ZBIO	Zenas BioPharma, Inc.	2,388,150	$60,611,247
3	KLRA	Kailera Therapeutics, Inc.	2,455,357	$54,091,514
4	BHVN	Biohaven Ltd. This page	2,936,507	$43,695,224

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$43,695,224	2,936,507	0.0%	Shares	Defined	2026-08-21
2026-03-31	$24,842,849	2,936,507	0.0%	Shares	Defined	2026-05-14
2025-12-31	$33,153,164	2,936,507	—	Shares	Defined	2026-04-01
No filing history on record for this holder in this stock.